Ultrapotent compound may help treat C. diff, reduce recurrence
Clostridioides difficile, or C. diff, is the leading cause of health care-associated infection in the U.S. Only two antibiotics, vancomycin and fidaxomicin, are FDA approved
Category: Lifestyle
New vulnerability found in lung squamous cancer may facilitate drug targeting
New cancer research by scientists at UNC Lineberger Comprehensive Cancer Center, and colleagues, shows the potential for targeting a specific circular RNA, known as CDR1as,
Research challenges conventional wisdom about key autism trait
A new study into the causes of sensorimotor impairments prevalent among autistic people could pave the way for better treatment and management in the future,
Novel neuroimaging study on dissociative symptoms reveals wounds of childhood trauma
Being traumatized can cause what are known as dissociative symptoms—such as experiencing amnesia, an out-of-body experience, feeling emotionally numb—which may help people cope. Experiencing these
Common pelvic pain drug is ineffective, study finds
A drug that is regularly used to treat chronic pelvic pain in women has been found to be no more effective than a placebo, a
Researchers set the stage to improve the efficiency of living kidney donor evaluations
Living kidney donation rates have remained stagnant over the last decade, and many potential living donors perceive the evaluation process to be lengthy and difficult
Age restrictions for handguns make little difference in homicides
In the United States, individual state laws barring 18- to 20-year-olds from buying or possessing a handgun make little difference in the rate of homicides